Michele Ferguson, MD is a practicing physician and Chief Medical Officer at Muse Bio, a San Francisco–based regenerative biology and biotech company pioneering menstrual blood–derived stem cells for therapeutic platforms.
She began her career in intensive care, then moved into frontline women’s health — caring for patients across fertility, perimenopause, menopause, and cardiometabolic disease. That combination of high-stakes ICU medicine and everyday women’s care gives her a rare perspective on what truly changes outcomes across a woman’s life.
Today, she brings more than a decade of clinical leadership to building the next generation of women’s health and reproductive longevity platforms. At Muse Bio, she leads clinical, regulatory, and translational strategy across menstrual stem cells, cell-free therapeutics, and reproductive tissue biology — helping turn cutting-edge science into real-world care for women.
